Research Topics
Species | Nelleke TolboomSummaryAffiliation: VU University Medical Center Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP bindingNelleke Tolboom
Departments of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
J Nucl Med 50:1464-70. 2009....
Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PETNelleke Tolboom
Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
J Nucl Med 50:191-7. 2009..The purpose of this study was to directly compare these tracers in patients with AD, patients with mild cognitive impairment (MCI), and healthy controls...
Test-retest variability of quantitative [11C]PIB studies in Alzheimer's diseaseNelleke Tolboom
Departments of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
Eur J Nucl Med Mol Imaging 36:1629-38. 2009....
Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findingsNelleke Tolboom
Department of Neurology and Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
Alzheimer Dis Assoc Disord 24:303-7. 2010..This, in combination with elevated levels of CSF t-tau and p-tau, has potential value in differential diagnosis of frontotemporal dementia from AD...
Simplified parametric methods for [11C]PIB studiesMaqsood Yaqub
Department of Nuclear Medicine and PET Research, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neuroimage 42:76-86. 2008..RPM2 and MRTM2 also provided best accuracy and precision in the simulation studies and are therefore the methods of choice for parametric analysis of clinical [11C]PIB studies...
Peripheral metabolism of [(18)F]FDDNP and cerebral uptake of its labelled metabolitesGert Luurtsema
Department of Nuclear Medicine and PET Research, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Nucl Med Biol 35:869-74. 2008..These labelled metabolites were reproduced in vitro using human hepatocytes. PET studies in rats showed that these polar metabolites can penetrate the blood-brain barrier and result in uniform brain uptake...
Evaluation of tracer kinetic models for analysis of [18F]FDDNP studiesMaqsood Yaqub
Department of Nuclear Medicine and PET Research, VU University Medical Centre, P O Box 7057, 1007 MB, Amsterdam, The Netherlands
Mol Imaging Biol 11:322-33. 2009..Different pharmacokinetic methods for [18F]FDDNP studies were evaluated using both simulations and clinical data...
Simplified parametric methods for [18F]FDDNP studiesMaqsood Yaqub
Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
Neuroimage 49:433-41. 2010..Furthermore, in simulations, RPM2 and MRTM2 provided the most accurate and precise BP(ND) estimates. RPM2 and MRTM2 are the methods of choice for parametric analysis of [(18)F]FDDNP studies...
Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET imagesNelleke Tolboom
Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, The Netherlands
J Neurol Neurosurg Psychiatry 81:882-4. 2010..To evaluate visual assessment of [(11)C]PIB and [(18)F]FDDNP PET images as potential supportive diagnostic markers for Alzheimer's disease (AD)...
[Amyloid-plaque imaging of the brain using PET]Rik Ossenkoppele
VU Medisch Centrum, Afd Nucleaire Geneeskunde and PET Research, Amsterdam, The Netherlands
Ned Tijdschr Geneeskd 155:A2981. 2011..In the future, amyloid imaging could also be useful for selecting patients for clinical trials and in evaluating the effects of disease modifying agents tailored at lowering Aβ burden...
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairmentMaja A A Binnewijzend
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
Neurobiol Aging 33:2018-28. 2012..Correlation with cognitive dysfunction demonstrated the clinical relevance of FC changes within the DMN. In conclusion, clinically relevant decreased FC within the DMN was observed in AD...
Blood-brain barrier P-glycoprotein function in Alzheimer's diseaseDaniëlle M E van Assema
Department of Nuclear Medicine and PET Research, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Brain 135:181-9. 2012....
